Smiths Group (LON:SMIN) Rating Reaffirmed
Investment analysts at RBC Capital Markets now has a GBX 900 target PPS on Smiths Group (LON:SMIN). RBC Capital Markets and their recent target PPS would indicate a potential downside of -8.81% from the company’s current price. The rating has been released in a comprehensive report on Tuesday, 8 December.
From a total of 19 analysts covering Smiths Group (LON:SMIN) stock, 7 rate it a ”Buy”, 6 a “Sell”, and 5 a ”Hold”. This means that 39% of the ratings are positive. The highest target price is GBX 1450 while the lowest target price is GBX 845. The mean of all analyst targets is GBX 1095.26 with a 11.72% above today’s (GBX 981.5) stock price. Smiths Group was the topic of 47 analyst reports since July 27, 2015 according to the firm StockzIntelligence Inc. HSBC upgraded shares on December 1 to “Hold” rating. Nomura maintained shares with “Buy” rating and GBX 1235 target share price in a report from a November 20. Stifel Nicolaus maintained SMIN stock in a recent report from November 26 with “Buy” rating. Panmure Gordon maintained the rating on November 19. Panmure Gordon has a “Sell” rating and a GBX 850 price target on shares. Finally, BNP Paribas maintained the stock with “Underperform” rating in a report issued on a November 20.
Approximately 156,379 shares of stock traded hands. Smiths Group plc (LON:SMIN) has declined 13.23% since May 11, 2015 and is downtrending. It has underperformed by 12.64% the S&P500.
Smiths Group plc is a technology company. The company has a market cap of 3.92 billion GBP. The Firm operates through five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. It has 15.9 P/E ratio. John Crane division offers mechanical seals, seal support systems, engineered bearings, power transmission couplings and filtration systems.